TORNTPHARM acquisition, merger or stake sale
as of Tue 3 Feb 15:30
TORRENT PHARMACEUTICALS L filed acquisition, merger or stake sale, from J.B. Chemicals & Pharmaceuticals Limited, its own share being 48.8% on Tue 3 Feb 2026.
Its size: the filing states no amount.
Where it came from
as of Tue 3 Feb 15:30
Sources
- Filed
- NSE · 2026-02-03 22:00 IST
- Document
raw/nse_announcement_docs/2026-02-03/ffa78bde8681_ffa78bde8681_TORNTPHARM_03022026220021_SE_Intimation_03022026.pdf· SHA-256 ffa78bde8681- Read from
- “48.80% of the equity share capital of JB Chemicals on a fully diluted basis” · page 1 · characters 1899–1974
- Read by
- claude-haiku-4-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed
- Measured against
- the company’s market value · as of 3 Feb 2026
- Kind
- acquisition, merger or stake sale
What such filings have been followed by
as of Tue 3 Feb 15:30
This filing has no record: its size is not measured, it states no amount, or it came on the same session as another kind.